Clinical Trials Directory

Trials / Unknown

UnknownNCT05756049

Procalcitonin Protocol Use to Guide Antibiotic Therapy Duration in the Intensive Care Unit

Status
Unknown
Phase
Study type
Observational
Enrollment
208 (estimated)
Sponsor
Methodist Health System · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

To compare and contrast antibiotic use and its effects on patient outcomes before and after the implementation of a PCT protocol in the ICU at Methodist Richardson Medical Center (MRMC).

Detailed description

Based on previous clinical trials, current literature supports the use of PCT levels in combination with clinical assessments to help determine optimal antibiotic therapy. On May 30, 2022, MRMC launched a PCT protocol in the ICU that allows clinical pharmacy specialists to order PCT levels in certain bacterial infections. In order to determine the effects of the protocol, a retrospective quasi-experimental review will be conducted

Conditions

Interventions

TypeNameDescription
OTHERcompare antibiotic duration of therapyTo compare antibiotic duration of therapy before and after the implementation of the PCT protocol in the ICU.

Timeline

Start date
2022-11-29
Primary completion
2024-11-29
Completion
2024-11-29
First posted
2023-03-06
Last updated
2024-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05756049. Inclusion in this directory is not an endorsement.